Published in Parkinsonism Relat Disord on January 01, 2007
Modulation of striatal projection systems by dopamine. Annu Rev Neurosci (2011) 4.84
MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. Mol Cell Neurosci (2010) 1.30
The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One (2012) 1.27
Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol (2009) 1.23
Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss. Cereb Cortex (2010) 0.99
Neuroregeneration in neurodegenerative disorders. BMC Neurol (2011) 0.98
Differential structural plasticity of corticostriatal and thalamostriatal axo-spinous synapses in MPTP-treated Parkinsonian monkeys. J Comp Neurol (2011) 0.97
Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? Neuroscience (2013) 0.96
Extracerebellar role for Cerebellin1: modulation of dendritic spine density and synapses in striatal medium spiny neurons. J Comp Neurol (2010) 0.94
Signaling pathways controlling the phosphorylation state of WAVE1, a regulator of actin polymerization. J Neurochem (2010) 0.93
Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist. Biol Psychiatry (2015) 0.92
Striatal spine plasticity in Parkinson's disease. Front Neuroanat (2010) 0.90
Striatal spine plasticity in Parkinson's disease: pathological or not? Parkinsonism Relat Disord (2009) 0.89
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? Philos Trans R Soc Lond B Biol Sci (2015) 0.89
Gender and manganese exposure interactions on mouse striatal neuron morphology. Neurotoxicology (2011) 0.88
Morphometric analysis in neurodegenerative disorders. Curr Protoc Toxicol (2010) 0.88
Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease. BMC Neurosci (2010) 0.88
A neurocomputational method for fully automated 3D dendritic spine detection and segmentation of medium-sized spiny neurons. Neuroimage (2010) 0.86
Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease. Brain Res Bull (2012) 0.86
Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease. Front Syst Neurosci (2011) 0.85
Endocannabinoid-dopamine interactions in striatal synaptic plasticity. Front Pharmacol (2012) 0.85
STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease. Proc Natl Acad Sci U S A (2015) 0.84
Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury. Toxicol Appl Pharmacol (2011) 0.83
Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion. Neurobiol Dis (2011) 0.83
An embryonic culture system for the investigation of striatal medium spiny neuron dendritic spine development and plasticity. J Neurosci Methods (2011) 0.83
L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia. Cereb Cortex (2016) 0.78
Morphological changes of glutamatergic synapses in animal models of Parkinson's disease. Front Neuroanat (2015) 0.76
Are the Symptoms of Parkinsonism Cortical in Origin? Comput Struct Biotechnol J (2016) 0.75
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature (2003) 16.48
The role of the basal ganglia in habit formation. Nat Rev Neurosci (2006) 8.68
Learning induces long-term potentiation in the hippocampus. Science (2006) 7.46
Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science (1998) 7.29
Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature (1994) 5.17
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci (2006) 4.98
Gene expression nervous system atlas (GENSAT). Nat Neurosci (2004) 4.74
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature (2007) 4.36
DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol (2004) 3.84
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron (2006) 3.58
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci (2002) 3.34
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci (2003) 3.25
A CaMKII-NeuroD signaling pathway specifies dendritic morphogenesis. Neuron (2004) 2.62
Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J Neurosci (1998) 2.55
The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci (2005) 2.25
D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade. J Neurosci (2000) 2.13
alphaCaMKII Is essential for cerebellar LTD and motor learning. Neuron (2006) 2.10
Targeting of calcium/calmodulin-dependent protein kinase II. Biochem J (2004) 2.08
Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci (2001) 1.98
Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat Rev Neurosci (2001) 1.92
Stabilization of dendritic arbor structure in vivo by CaMKII. Science (1998) 1.91
Differential inactivation of postsynaptic density-associated and soluble Ca2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. J Neurochem (1997) 1.71
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology (2005) 1.56
Dopamine modulates release from corticostriatal terminals. J Neurosci (2004) 1.54
Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience (2005) 1.51
Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J Neurophysiol (2000) 1.51
Short- and long-term synaptic depression in rat neostriatum. J Neurophysiol (1993) 1.51
Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2. J Biol Chem (2005) 1.46
In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation. Proc Natl Acad Sci U S A (1997) 1.40
Differential modulation of Ca2+/calmodulin-dependent protein kinase II activity by regulated interactions with N-methyl-D-aspartate receptor NR2B subunits and alpha-actinin. J Biol Chem (2005) 1.28
Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res (1989) 1.27
Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol (2001) 1.21
Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. Eur J Neurosci (2005) 1.20
Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci U S A (2001) 1.16
Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neuroscience (2007) 1.10
Calcium/calmodulin-dependent protein kinase II (CaMKII) localization acts in concert with substrate targeting to create spatial restriction for phosphorylation. J Biol Chem (2004) 1.08
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J Neurosci (2004) 1.06
Dendritic spines shaped by synaptic activity. Curr Opin Neurobiol (2000) 1.06
Brain plasticity and mental processes: Cajal again. Nat Rev Neurosci (2006) 1.02
Calcium channel blockers and beta-blockers in relation to Parkinson's disease. Parkinsonism Relat Disord (2006) 1.00
Dendritic spines for neuroprotection: a hypothesis. Trends Neurosci (1995) 0.94
Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Brain Res (1999) 0.89
Enhancement of N-methyl-D-aspartate (NMDA) immunoreactivity in residual dendritic spines in the caudate-putamen nucleus after chronic haloperidol administration. Synapse (1999) 0.81
A potassium channel blocker induces a long-lasting enhancement of corticostriatal responses. Neuropharmacology (2005) 0.81
A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell (2008) 6.16
Calmodulin kinase II inhibition protects against structural heart disease. Nat Med (2005) 5.87
Concern Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation (2002) 4.16
Retracted L-type Ca2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII. Mol Cell (2006) 2.49
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron (2006) 2.00
Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci (2010) 1.99
Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy. Circulation (2006) 1.85
Calmodulin kinase II activity is required for normal atrioventricular nodal conduction. Heart Rhythm (2005) 1.63
Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2. J Biol Chem (2005) 1.46
CaV1.2 beta-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations. Proc Natl Acad Sci U S A (2010) 1.42
Alcohol exposure alters NMDAR function in the bed nucleus of the stria terminalis. Neuropsychopharmacology (2009) 1.41
Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol Pharmacol (2008) 1.38
Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome. Neurobiol Dis (2010) 1.33
A mechanism for the direct regulation of T-type calcium channels by Ca2+/calmodulin-dependent kinase II. J Neurosci (2003) 1.31
Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: the neurabin I/PP1 complex regulates cell morphology. Mol Cell Biol (2002) 1.29
Differential modulation of Ca2+/calmodulin-dependent protein kinase II activity by regulated interactions with N-methyl-D-aspartate receptor NR2B subunits and alpha-actinin. J Biol Chem (2005) 1.28
GluN2B subunit deletion reveals key role in acute and chronic ethanol sensitivity of glutamate synapses in bed nucleus of the stria terminalis. Proc Natl Acad Sci U S A (2012) 1.21
Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. Eur J Neurosci (2005) 1.20
Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J Neurosci (2010) 1.19
Retracted Cytoskeletal disrupting agents prevent calmodulin kinase, IQ domain and voltage-dependent facilitation of L-type Ca2+ channels. J Physiol (2002) 1.16
Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein. Protein Expr Purif (2003) 1.13
CaMKIIalpha enhances the desensitization of NR2B-containing NMDA receptors by an autophosphorylation-dependent mechanism. Mol Cell Neurosci (2005) 1.11
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Nat Neurosci (2013) 1.11
Differential regulated interactions of calcium/calmodulin-dependent protein kinase II with isoforms of voltage-gated calcium channel beta subunits. Biochemistry (2008) 1.08
Ca2+-dependent facilitation of Cav1.3 Ca2+ channels by densin and Ca2+/calmodulin-dependent protein kinase II. J Neurosci (2010) 1.08
CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction. J Mol Med (Berl) (2006) 1.08
The neuronal actin-binding proteins, neurabin I and neurabin II, recruit specific isoforms of protein phosphatase-1 catalytic subunits. J Biol Chem (2002) 1.07
Retracted C terminus L-type Ca2+ channel calmodulin-binding domains are 'auto-agonist' ligands in rabbit ventricular myocytes. J Physiol (2003) 1.07
Molecular basis for the modulation of native T-type Ca2+ channels in vivo by Ca2+/calmodulin-dependent protein kinase II. J Clin Invest (2006) 1.05
Retracted A dynamic alpha-beta inter-subunit agonist signaling complex is a novel feedback mechanism for regulating L-type Ca2+ channel opening. FASEB J (2005) 1.04
Spinophilin stabilizes cell surface expression of alpha 2B-adrenergic receptors. J Biol Chem (2003) 1.03
Transparency Is the Key to Quality. J Biol Chem (2015) 0.99
Suppression of dynamic Ca(2+) transient responses to pacing in ventricular myocytes from mice with genetic calmodulin kinase II inhibition. J Mol Cell Cardiol (2006) 0.98
Substrate-selective and calcium-independent activation of CaMKII by α-actinin. J Biol Chem (2012) 0.97
Calmodulin kinase is functionally targeted to the action potential plateau for regulation of L-type Ca2+ current in rabbit cardiomyocytes. J Physiol (2004) 0.94
Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice. Mol Cell Neurosci (2011) 0.93
A protein phosphatase-1gamma1 isoform selectivity determinant in dendritic spine-associated neurabin. J Biol Chem (2004) 0.93
Developmentally regulated alternative splicing of densin modulates protein-protein interaction and subcellular localization. J Neurochem (2008) 0.93
The orexins/hypocretins and schizophrenia. Schizophr Bull (2007) 0.93
Characterization of a central Ca2+/calmodulin-dependent protein kinase IIalpha/beta binding domain in densin that selectively modulates glutamate receptor subunit phosphorylation. J Biol Chem (2011) 0.92
Selective targeting of the gamma1 isoform of protein phosphatase 1 to F-actin in intact cells requires multiple domains in spinophilin and neurabin. FASEB J (2008) 0.92
CaMKII associates with CaV1.2 L-type calcium channels via selected beta subunits to enhance regulatory phosphorylation. J Neurochem (2009) 0.91
Genetic inhibition of CaMKII in dorsal striatal medium spiny neurons reduces functional excitatory synapses and enhances intrinsic excitability. PLoS One (2012) 0.91
Conformational changes underlying calcium/calmodulin-dependent protein kinase II activation. EMBO J (2011) 0.90
Oxidation of calmodulin alters activation and regulation of CaMKII. Biochem Biophys Res Commun (2007) 0.90
Association of protein phosphatase 1 gamma 1 with spinophilin suppresses phosphatase activity in a Parkinson disease model. J Biol Chem (2008) 0.89
Inhibition of pancreatic β-cell Ca2+/calmodulin-dependent protein kinase II reduces glucose-stimulated calcium influx and insulin secretion, impairing glucose tolerance. J Biol Chem (2014) 0.88
Identification and validation of novel spinophilin-associated proteins in rodent striatum using an enhanced ex vivo shotgun proteomics approach. Mol Cell Proteomics (2010) 0.87
CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling. Nat Neurosci (2013) 0.86
Age-dependent targeting of protein phosphatase 1 to Ca2+/calmodulin-dependent protein kinase II by spinophilin in mouse striatum. PLoS One (2012) 0.86
Differential localization of protein phosphatase-1alpha, beta and gamma1 isoforms in primate prefrontal cortex. Cereb Cortex (2005) 0.86
Differential association of postsynaptic signaling protein complexes in striatum and hippocampus. J Neurochem (2012) 0.84
Metabolic activation of CaMKII by coenzyme A. Mol Cell (2013) 0.82
A potassium channel blocker induces a long-lasting enhancement of corticostriatal responses. Neuropharmacology (2005) 0.81
Quantitative proteomics analysis of CaMKII phosphorylation and the CaMKII interactome in the mouse forebrain. ACS Chem Neurosci (2015) 0.80
Metabolic regulation of CaMKII protein and caspases in Xenopus laevis egg extracts. J Biol Chem (2013) 0.80
Localization of myocyte enhancer factor 2 in the rodent forebrain: regionally-specific cytoplasmic expression of MEF2A. Brain Res (2009) 0.80
Calmodulin kinase II inhibition disrupts cardiomyopathic effects of enhanced green fluorescent protein. J Mol Cell Cardiol (2007) 0.76
REEPing the benefits of an animal model of hereditary spastic paraplegia. J Clin Invest (2013) 0.75